Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulant Therapy for Portal Vein Thrombosis in Cirrhosis
NCT07132515Phase 4Recruiting
- Sponsor
- Mansoura University
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin, warfarin and apixaban in portal vein thrombosis (PVT) (3 arms), sponsored by Mansoura University. Primary endpoint: Portal Vein Thrombosis at 6 months. Started Aug 2023; status: recruiting.
02
Drugs
enoxaparinwarfarinapixaban
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT07132515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07132515.